Administration of a dose of 15 mg/kg of the recreationally used drug 3,4-me
thylenedioxymethamphetamine (MDMA or "ecstasy") to Dark Agouti rats resulte
d in an acute hyperthermic response which was followed 7 days later by a ma
rked (approximate to 45%) loss off 5-HT and its metabolite 5-HIAA in cortex
, hippocampus and striatum and a similar loss of [H-3]-paroxetine binding i
n cortex. These losses reflect the MDMA-induced neurotoxic degeneration of
5-HT nerve endings. Administration of pentobarbitone (40 mg/kg) concurrentl
y with MDMA produced a significant attenuation of the neurotoxic damage, bu
t also acute hypothermia. When the temperature of the MDMA plus pentobarbit
one-treated group was kept elevated to that of the MDMA-treated group by th
e use of a homeothermic blanket, the neuroprotective effect of pentobarbito
ne was lost. These data demonstrate that pentobarbitone appears to possess
no intrinsic neuroprotective activity and the previously reported activity
is due to a hypothermic action of the drug.